AbCellera Biologics investor relations material

Listen to the latest call from AbCellera Biologics

AbCellera Biologics, Inc. operates as a biotechnology company. The Company offers antibody discovery platform that accelerates the design of therapeutic antibodies and helps researchers discover new treatments for people with cancer or Alzheimer's disease. The company's platform discovers and characterizes fully human antibodies from natural immune responses in order to provide insights into how best to stimulate the human immune system.

  • Ticker

  • Country


Dig deeper into the AbCellera Biologics fundamentals on Quartr.